SRZN — Surrozen Income Statement
0.000.00%
- $28.79m
- $1.50m
- 11
- 35
- 34
- 16
Annual income statement for Surrozen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 12.5 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25.1 | 32.8 | 54.4 | 56.8 | 45.8 |
Operating Profit | -25.1 | -32.8 | -54.4 | -44.3 | -45.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -24.4 | -32.7 | -54.6 | -36 | -43 |
Net Income After Taxes | -24.4 | -32.7 | -54.6 | -36 | -43 |
Net Income Before Extraordinary Items | |||||
Net Income | -24.4 | -32.7 | -54.6 | -36 | -43 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -24.4 | -32.7 | -54.6 | -36 | -43 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -10.4 | -14 | -23.4 | -15.6 | -19.8 |
Dividends per Share |